Which are the causes of Hunter syndrome?

Hunter syndrome, also known as Mucopolysaccharidosis type II (MPS II), is a rare, life-limiting genetic metabolic disorder caused by a deficiency in the enzyme iduronate-2-sulfatase (I2S). This deficiency prevents the body from breaking down complex sugar molecules called glycosaminoglycans (GAGs), leading to their toxic accumulation in cells and tissues throughout the body.

What causes Hunter syndrome at the genetic level?

Hunter syndrome is caused by mutations in the IDS gene, which provides instructions for making the I2S enzyme. Think of the I2S enzyme as a "cellular janitor" responsible for cleaning up GAGs; when the gene is mutated, the janitor is either missing or malfunctioning, causing "trash" (GAGs) to pile up inside cells, which disrupts normal organ function. Because the IDS gene is located on the X chromosome, Hunter syndrome primarily affects males, who only have one X chromosome and thus no "backup" copy to compensate for the mutation.

Is Hunter syndrome hereditary?

Yes, Hunter syndrome is an X-linked recessive genetic condition. This means that mothers who carry the mutation on one of their X chromosomes have a 50% chance of passing the condition to their sons. It is not caused by environmental triggers, diet, or lifestyle factors; it is an inherited metabolic disease present from conception.

What are the key mechanisms of Hunter syndrome?

The pathology of Hunter syndrome is driven by the systemic buildup of GAGs. This accumulation leads to several clinical manifestations, including:

• Skeletal and joint stiffness: Restriction of movement and bone abnormalities.


• Organomegaly: Enlargement of the liver and spleen.


• Respiratory issues: Airway obstruction caused by tissue thickening.


• Neurological decline: In severe forms, GAG buildup in the brain leads to progressive cognitive impairment.

Current research into the etiology of Hunter syndrome

While the genetic cause of Hunter syndrome is well-understood, current research focuses on improving enzyme replacement therapies (ERT) and finding ways to cross the blood-brain barrier to treat neurological symptoms. At DiseaseMaps.org, 66 people with Hunter syndrome are sharing their experiences, which helps researchers better understand the natural history of this complex disease.

Next steps

• Consult a clinical geneticist to discuss family screening and carrier testing.


• Connect with the 66 community members at DiseaseMaps.org to share experiences.


• Review clinical trial databases like ClinicalTrials.gov for the latest gene therapy research.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hunter Syndrome.


• Orphanet: Mucopolysaccharidosis type II.


• OMIM (Online Mendelian Inheritance in Man): Iduronate-2-sulfatase gene (#309900).


• National MPS Society: Information on MPS II management.